Target intelligence / Profile preview

Nebulin (NEB)

Target
NEB
Molecular classification
Other (specifically, structural cytoskeletal protein), actin-binding protein
01

Overview

Nebulin is a giant cytoskeletal protein of approximately 600–900 kDa that forms an integral part of the skeletal muscle thin filament. Composed of a high number of repeating actin-binding domains, nebulin stabilizes actin filaments, specifies thin filament lengths, and organizes the contractile machinery of muscle cells. Its C-terminal SH3 domain is embedded in the sarcomere Z-disc, where it binds various partners, including α-actinin and titin, contributing to Z-disc structure and myofibril alignment. Mutations in the NEB gene cause nemaline myopathy (often designated as "nemaline myopathy type 2"), indicating the essential role of nebulin in muscle development and function. Beyond its structural roles, nebulin has been implicated in actin nucleation (with N-WASP) and calcium homeostasis in muscle fibers. Its function and expression are largely restricted to skeletal muscle, and it is not a recognized druggable or pharmacological target at this time.

Other names
NEBNEB177Dnemaline myopathy type 2AMC6NEM2
02

Mechanism of action

Not applicable

03

Biological functions

Regulation of thin filament length in skeletal muscleStabilization of actin filamentsRegulation of muscle contractionAssembly and maintenance of the sarcomere Z-disc structureMyofibrillogenesis and myofibril organizationActin cytoskeleton organization
04

Disease associations

Causative for nemaline myopathy (congenital myopathy characterized by muscle weakness)Involved in congenital myopathies linked to muscle function and development
05

Safety considerations

Not applicable for therapeutic targeting, but loss or mutation of nebulin leads to serious muscle pathology, such as muscle weakness and early lethality in animal models due to structural muscle defects
06

Biomarkers

NEB gene mutations serve as diagnostic markers for nemaline myopathy and related disorders

Beyond the preview

Go deeper on Nebulin (NEB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nebulin (NEB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call